bioMerieux (FR:BIM)
:BIM
France Market

bioMerieux (BIM) Technical Analysis

Compare
6 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
0Neutral
8Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
bioMerieux’s (BIM) Moving Averages Convergence Divergence (MACD) indicator is 0.56, suggesting bioMerieux is a Buy.
bioMerieux’s (BIM) 20-Day exponential moving average is 115.86, while bioMerieux’s (BIM) share price is €114.7, making it a Sell.
bioMerieux’s (BIM) 50-Day exponential moving average is 114.13, while bioMerieux’s (BIM) share price is €114.7, making it a Buy.

bioMerieux (BIM) Pivot Points

Apr 07, 2025, 01:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
113.83
114.87
115.63
116.67
117.43
118.47
119.23
Fibonacci
114.87
115.55
115.98
116.67
117.35
117.78
118.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

bioMerieux (BIM) Moving Averages

Apr 07, 2025, 01:23 AM
Period
Simple
Exponential
MA5
116.08Sell
116.28Sell
MA10
116.43Sell
116.22Sell
MA20
115.66Sell
115.86Sell
MA50
115.30Sell
114.13Buy
MA100
108.99Buy
110.99Buy
MA200
105.23Buy
106.43Buy
bioMerieux’s (BIM) 10-Day exponential moving average is 116.22, while bioMerieux’s (BIM) share price is €114.7, making it a Sell.
bioMerieux’s (BIM) 100-Day exponential moving average is 110.99, while bioMerieux’s (BIM) share price is €114.7, making it a Buy.
bioMerieux’s (BIM) stock price is €114.7 and bioMerieux’s (BIM) 50-day simple moving average is 115.30, creating a Sell signal.
bioMerieux’s (BIM) stock price is €114.7 and bioMerieux’s (BIM) 100-day simple moving average is 108.99, creating a Buy signal.
bioMerieux’s (BIM) stock price is €114.7 and bioMerieux’s (BIM) 200-day simple moving average is 105.23, creating a Buy signal.

bioMerieux (BIM) Technical Indicators

Apr 07, 2025, 01:23 AM
Name
Value
Implied Action
RSI (14)
46.36
Neutral
STOCH (9,6)
38.09
Neutral
STOCHRSI (14)
61.03
Neutral
MACD (12,26)
0.56
Buy
ADX (14)
23.23
Neutral
Williams %R
-61.97
Buy
CCI (14)
-40.23
Neutral
ATR (14)
2.10
-
Ultimate Oscillator
42.10
Neutral
ROC
-0.17
Sell
bioMerieux’s (BIM) Relative Strength Index (RSI) is 46.36, creating a Neutral signal.
bioMerieux’s (BIM) Trend Strength Indicator (ADX) is 23.23, creating a Neutral signal.
bioMerieux’s (BIM) Commodity Channel Index (CCI) is -40.23, creating a Neutral signal.
bioMerieux’s (BIM) Price Rate of Change (ROC) is -0.17, creating a Sell signal.

FAQ

Is BIM a Buy, Hold, or Sell?
Based on BIM’s technical indicators, BIM is a Sell.
    What is BIM’s RSI (14)?
    BIM’s RSI (14) is 46.36, which suggests BIM is a Neutral.
      What is BIM’s MACD?
      BIM’s MACD is 0.56, which suggests BIM is a Buy.
        What is BIM’s 5-day moving average?
        BIM’s 5-day moving average is 116.08, which suggests BIM is a Sell.
          What is BIM’s 20-day moving average?
          BIM 20-day moving average is 115.66, which suggests BIM is a Sell.
            What is BIM’s 50-day moving average?
            BIM’s 50-day moving average is 115.30, which suggests BIM is a Sell.
              What is BIM’s 200-day moving average?
              BIM’s 200-day moving average is 105.23, which suggests BIM is a Buy.
                What is BIM’s Williams % R (14)?
                BIM’s Williams % R (14) is -61.97, which suggests BIM is a Buy.
                  What is BIM’s CCI (14)?
                  BIM’s CCI (14) is -40.23, which suggests BIM is a Neutral.
                    What is the share price of bioMerieux?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis